3861 results for «576»
3861 results
Randomised trials: substudies and extended follow-up - A quick update
15 May 2024 – From EuroPCR 2024
This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...
Management of patient with coronary artery disease and left ventricle dysfunction
15 May 2024 – From EuroPCR 2024
This session focuses on the management of patients with stable coronary artery disease and left ventricular dysfunction. Experts will discuss the role of mechanical circulatory support devices in these patients, as well as the diagnosis and treatment of microvascular angina, which can be a challenging complication...
TEER for primary mitral regurgitation - LIVE case
15 May 2024 – From EuroPCR 2024
A 76-year-old male, with previous CABG in 2015, hypertension, diabetes, and pulmonary hypertension (WHO2), presented with severe symptomatic primary MR (P3 flail).
The operators implanted 1 MitraClip (XTW) step-by-step, from the transseptal puncture to the closure, guided by TEE echo and under general anaesthesia, via the venous...
Nightmare cases
15 May 2024 – From EuroPCR 2024
Asymptomatic severe aortic stenosis: Will these trials change my practice?
16 May 2024 – From EuroPCR 2024
This session, in collaboration with Partners in Learning, explores the emerging evidence on the use of transcatheter aortic valve implantation (TAVI) in patients with asymptomatic severe aortic stenosis. It covers data from registries and randomized controlled trials, the current guideline recommendations, and the potential impact of...
Edge-to-edge repair for primary mitral regurgitation: the good, the bad and the ugly
16 May 2024 – From EuroPCR 2024
Discover how to select suitable patients for TEER of primary mitral regurgitation, tackle anatomical challenges, understand the technique's limits, and gain insights into managing complexities and identifying cases where TEER may not be ideal.
Bicuspid disease - All you need to know
16 May 2024 – From EuroPCR 2024
This session is ideal if you want to understand the anatomical features of bicuspid aortic stenosis, learn about the latest post-TAVI clinical outcomes in bicuspid aortic valves, grasp key considerations for TAVI sizing in these cases, and analyze both self-expanding and balloon-expandable TAVI procedures in bicuspid...
TAVI - Step by step
16 May 2024 – From EuroPCR 2024
This interactive session provides a step-by-step guide on performing minimalist TAVI procedures. Attendees will learn how to optimize TAVI for speed and safety, with a deep dive on the safest techniques for large-bore arterial access and vessel closure. Key topics include femoral access, fluoroscopic projections, crossing...
PCI to treat the bystander disease in STEMI patients: who, when and how?
16 May 2024 – From EuroPCR 2024
Watch this case-based session on PCI for STEMI to see how the guidelines are influenced by the COMPLETE trial. Learn why and how physiology can guide intermediate lesions, the importance of intracoronary imaging guidance, the value of complete revascularization in STEMI patients, the optimal method for...
Intracoronary imaging to guide management in ACS
16 May 2024 – From EuroPCR 2024
This session focuses on the role of intracoronary imaging, specifically IVUS and OCT, in the management of Acute Coronary Syndrome (ACS). Participants will learn when intracoronary imaging can facilitate diagnosis and guide PCI, as well as discuss image interpretation in the setting of ACS.
Upgrade to retrograde: when and how?
16 May 2024 – From EuroPCR 2024
This session delves into the decision-making for transitioning to a retrograde approach in CTO PCI, covering effective techniques and safety considerations for successful outcomes, through cases involving antegradely induced hematomas and ambiguous CTO caps, alongside severe distal atherosclerosis.
Acute and chronic right ventricular failure: focus on the weak link
16 May 2024 – From EuroPCR 2024
This session discusses new diagnostic and therapeutic aspects of shock due to right ventricular infarction, explores why and how the failing right ventricle contributes to worsening heart failure, and examines device-based treatment opportunities for chronic right ventricular and tricuspid valve failure, including repair vs replacement. It...
Essentials in the management of calcified coronary stenosis
16 May 2024 – From EuroPCR 2024
This session focuses on the essentials of managing calcified coronary stenosis, including diagnostic pitfalls, selection strategies for appropriate plaque modification devices, and the safe and effective adoption of specific tools and techniques. Through interactive case discussions, attendees will learn how to effectively evaluate and treat calcified...
Complication occurring during PCI of calcified coronary lesions
17 May 2024 – From EuroPCR 2024
Join this in-depth session on the complications encountered during PCI of calcified coronary lesions, featuring real-world challenges like no flow with coronary dissection, stuck wires, and non-dilatable lesions. From the "Kokeshi phenomenon" to IVL-induced RCA dissection, this session highlights key lessons and red flags, emphasizing the...
Management of PCI complications - Part 2
17 May 2024 – From EuroPCR 2024
This session focuses on the management of various PCI complications, including iatrogenic dissection after diagnostic coronary angiography, sinus node artery occlusion, a stuck 6F guide in the axillary artery, and the retrieval of a broken balloon. The session features a series of case presentations and discussions,...
TAVI: how to deal with aortic regurgitation
16 May 2024 – From EuroPCR 2024
This session will explore various cases of TAVI for the management of aortic regurgitation, including patients with pure aortic regurgitation, large annuli, low coronary height, and left ventricular assist devices. Discussions will focus on the transcatheter approach, device selection, and techniques to address these challenging scenarios.
Management of LAA closure complications
16 May 2024 – From EuroPCR 2024
This session explores the various complications that can arise during left atrial appendage (LAA) closure procedures, including pericardial effusion, device embolisation, and procedural strokes. Learn how to identify risk factors, prevent these complications, and effectively manage them through case-based discussions and expert guidance.
Optimising the procedural techniques to treat calcified coronary lesions
16 May 2024 – From EuroPCR 2024
This session will provide insights into various techniques and strategies for treating severely calcified coronary lesions. Participants will learn about the use of IVUS guidance, rotational atherectomy, and other plaque modification tools to overcome challenging calcified lesions and achieve optimal stent deployment.
Acute coronary syndromes due to coronary dissection
16 May 2024 – From EuroPCR 2024
This session will explore various cases of acute coronary syndromes caused by coronary dissection. Participants will learn about the diagnosis, management, and treatment strategies for spontaneous coronary artery dissection, including the use of imaging and interventional techniques to address these challenging cases.
How to solve tricky coronary complications
16 May 2024 – From EuroPCR 2024
From balloon rupture during double-kissing crush stenting to a successful bailout for delayed coronary obstruction post-TAVI, and an unforeseen complication after chimney stenting in a high-risk patient, the session covers it all. Learn about the nuclear mushroom phenomenon during PCI in a calcified LAD, strategies for...
